[1]罗卓荆, 毕龙. 我国骨缺损修复的成就与展望[J]. 空军军医大学学报, 2022, 43(4): 263-267.
[2]Liu Z, Chen X M, Ruan Z, et al. Genetic analysis of comorbidities between osteoarthritis, sarcopenia, and osteoporosis[J]. Exp Gerontol, 2025, 206: 112788.
[3]Avin K G, Bloomfield S A, Gross T S, et al. Biomechanical aspects of the muscle-bone interaction[J]. Curr Osteoporos Rep, 2015, 13(1): 1-8.
[4]He Y T, Wang Y X, Weng K H, et al. Roles of skeletal muscle-derived exosomes in osteoporosis[J]. J Transl Med, 2025, 23(1): 1307.
[5]Meng F Y, Xue X, Yin Z F, et al. Research progress of exosomes in bone diseases: mechanism, diagnosis and therapy[J]. Front Bioeng Biotechnol, 2022, 10: 866627.
[6]Wang Z K, Zhao Z H, Gao B, et al. Exosome mediated biological functions within skeletal microenvironment[J]. Front Bioeng Biotechnol, 2022, 10: 953916.
[7]Vander Heiden M G, Cantley L C, Thompson C B. Understanding the Warburg effect: the metabolic requirements of cell proliferation[J]. Science, 2009, 324(5930): 1029-1033.
[8]Wu J H, Hu M, Jiang H, et al. Endothelial cell-derived lactate triggers bone mesenchymal stem cell histone lactylation to attenuate osteoporosis[J]. Adv Sci, 2023, 10(31): 2301300.
[9]Dumic-Cule I, Pecina M, Jelic M, et al. Bone regeneration: a review of current treatment strategies[J]. Int Orthop, 2015, 39(5): 1005-1011.
[10]Zhang J Z, Li S G, He H Y, et al. Clinical guidelines for indications, techniques, and complications of autogenous bone grafting[J]. Chin Med J, 2024, 137(1): 5-7.
[11]Santoro A, Voto A, Fortino L, et al. Bone defect treatment in regenerative medicine: exploring natural and synthetic bone substitutes[J]. Int J Mol Sci, 2025, 26(7): 3085.
[12]Wang J C, Liu S Z, Li J Y, et al. Roles for miRNAs in osteogenic differentiation of bone marrow mesenchymal stem cells[J]. Stem Cell Res Ther, 2019, 10(1): 197.
[13]Quek J, Vizetto-Duarte C, Teoh S H, et al. Towards stem cell therapy for critical-sized segmental bone defects: current trends and challenges on the path to clinical translation[J]. J Funct Biomater, 2024, 15(6): 145.
[14]Gao Q M, Liu J L, Wang M K, et al. Biomaterials regulates BMSCs differentiation via mechanical microenvironment[J]. Biomater Adv, 2024, 157: 213738.
[15]Tkach M, Théry C. Communication by extracellular vesicles: where we are and where we need to go[J]. Cell, 2016, 164(6): 1226-1232.
[16]Wang X, Xia J Y, Yang L, et al. Recent progress in exosome research: isolation, characterization and clinical applications[J]. Cancer Gene Ther, 2023, 30(8): 1051-1065.
[17]Luo J, Pu Q, Wu X Q. Recent advances of exosomes derived from skeletal muscle and crosstalk with other tissues[J]. Int J Mol Sci, 2024, 25(20): 10877.
[18]Mytidou C, Koutsoulidou A, Katsioloudi A, et al. Muscle-derived exosomes encapsulate myomirs and are involved in local skeletal muscle tissue communication[J]. FASEB J, 2021, 35(2): e21279.
[19]Luo J, Zhang D Y, Pu Q, et al. Skeletal muscle-derived exosomes selectively coated miRNAs and participate in myoblast proliferation and differentiation mediated by miR-4331-3p[J]. Int J Biol Macromol, 2024, 281(Part 1): 136225.
[20]Shen L Y, Hu G L, Karner C M. Bioenergetic metabolism in osteoblast differentiation[J]. Curr Osteoporos Rep, 2022, 20(1): 53-64.
[21]Minami E,Sasa K,Yamada A,et al.Lactate-induced histone lactylation by p300 promotes osteoblast differentiation[J]. PLoS One, 2023, 18(12): e0293676.
[22]Ning K T, Liu S Q, Yang B Q, et al. Update on the effects of energy metabolism in bone marrow mesenchymal stem cells differentiation[J]. Mol Metab, 2022, 58: 101450.
[23]Ji X, Seeley R, Li K, et al. Genetic activation of glycolysis in osteoblasts preserves bone mass in type I diabetes[J]. Cell Chem Biol, 2023, 30(9): 1053-1063.e5.
[24]Jin Z X, Lee B. Boosting glycolysis to combat fragile bone in type 1 diabetes[J]. Cell Chem Biol, 2023, 30(9): 1002-1003.
[25]Xu N, Cui G Z, Zhao S Y, et al. Therapeutic effects of mechanical stress-induced C2C12-derived exosomes on glucocorticoid-induced osteoporosis through miR-92a-3p/PTEN/AKT signaling pathway[J]. Int J Nanomedicine, 2023, 18: 7583-7603.
[26]Duan P, Yu Y L, Cheng Y N, et al. Exosomal miR-1a-3p derived from glucocorticoid-stimulated M1 macrophages promotes the adipogenic differentiation of BMSCs in glucocorticoid-associated osteonecrosis of the femoral head by targeting Cebpz[J]. J Nanobiotechnology, 2024, 22(1): 648.
[27]Huang X Q, Zhao Z Q, Zhan W Q, et al. MiR-21-5p enriched exosomes from human embryonic stem cells promote osteogenesis via YAP1 modulation[J]. Int J Nanomed, 2024, 19: 13095-13112.
|